Question
It appears this topic was covered in this forum back in 2012 and the HIDA conference was suggested as a possible resource. I've heard both positive and negative experiences concerning finding medical device distribution partners at HIDA and was hopin...
As originally asked by Erin Seiler, MBA Account Manager, Color & Additives North America at PolyOne A huge trend in labeling we are seeing on the manufacturing end, is a change from stickers or other forms of identification to laser marking technolog...
An independent reviewer is required for Design Reviewes. The problem in small start-up companies is that everyone is involved in the process and no one is really independent, on the other hand an external consultant may be very expensive for those co...
Hi all. does anybody know how one can find out which NBs have already been accredited? I know BSI have, they naturally boasted being the first ones. but is there some list or do I have to screen the NANDO? source: https://www.linkedin.com/groups/2070...
Hello everyone,First, thank you for accepting me in your group.Can sterile medical devices be re-sterilized and used as new and according to standards/lows if they expired (as a product) but haven't been used? Re-packaging is also required?Thank you....
I recently reviewed a sterilization validation protocol for a client and I thought some of you might be interested in the things that needed to be modified:1. Make sure you specify the revision of all standards referenced and make sure the version is...
First, I have to say how liberating it is to be writing you on my own site versus LinkedIn. I literally feel a wave of relief washing over me. First, I don't have to count characters. Second, I've already used italics(!), something LinkedIn doesn't ...
What is considered best practice for assessing effectiveness of change control actions within the QMS? I am wondering if a CC file remains open during this period or whether it is closed at execution and then tracked separately, e.g. as a CAPA. Alter...
Why I ask this? As a physician sometimes I have a feeling that in this group I'm not at home because it's mainly a group of businessmen, salesmen, distributors, engineers and others outside health practice with quite another way of thinking. Many of ...
I met a molecular biologist last week at BRINK 2015 (which was excellent). He's turned his attention to oncology. I paraphrase, but he basically asked if we knew any billionaires with cancer. He wasn't being elitist. Or looking to deny service to any...